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Introduction and Aim: Suboptimal health‐related quality of life and lowered employ‐
ment rates found in a previous study in young adults (YA) with congenital coagulation 
disorders (CCD) in the Netherlands underline the need for more insight into profes‐
sional functioning of YA with CCD and into determinants of professional 
functioning.
Methods: Young adults (18‐30 years) with CCD participated in a cross‐sectional 
study. Professional functioning was assessed with the Work Productivity and Activity 
Impairment questionnaire (WPAI). Potential determinants were assessed with the 
Course of Life Questionnaire (CoLQ), Pediatric Quality of Life Inventory Young Adult 
version (PedsQL_YA), Illness Cognition Questionnaire (ICQ) and Haemophilia 
Activities List (HAL). Logistic regression analyses were performed in the complete 
sample of YA with CCD, and in YA men with haemophilia separately, to examine de‐
terminants of WPAI outcomes.
Results: Ninety‐four YA (77 men; mean age 24.1 years, SD 3.5 and 17 women; mean 
age 24.5 years, SD 3.8) with CCD (74% haemophilia A/B) participated. 74.5% of YA 
were paid employed for on average 30 hours per week. Of these, more than a quarter 
reported work impairment. Older age and a non‐severe type of haemophilia (in the 
sample of YA men with haemophilia) were associated with successful (paid) employ‐
ment. No variables were associated with professional functioning (expressed as 
Presenteeism and Overall work impairment) in patients with CCD or haemophilia.
Conclusion: Three‐quarters of YA with CCD were successful in finding paid employ‐
ment. Though absenteeism was low, YA with paid employment needs attention as a 
considerable part experienced work impairment.
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1  | INTRODUC TION
Haemophilia A and B and von Willebrand disease (VWD) are the most 
common congenital coagulation disorders (CCD) identified.1 Congenital 
coagulation disorders are a result of a deficiency of the blood clotting 
system, in which bleeding is prolonged and excessive, and may occur 
spontaneous or posttraumatic.2 Haemophilia is X‐linked; women are 
carriers and men are affected. Other congenital coagulation disorders, 
such as VWD, have an autosomal inheritance pattern and affect both 
men and women. For women with coagulation disorders, heavy men‐
struation and postpartum bleeding are common.3
Since the ‘80s, the use of plasma concentrates of coagulation fac‐
tors became common. This enabled to start prophylactic treatment 
in patients with severe haemophilia (<1% clotting factor VIII or IX 
present in the blood) in order to prevent bleeding and joint damage, 
ultimately allowing patients to maintain a near normal lifestyle with 
little risk for arthropathy.4 Still, children and (young) adults growing 
up with coagulation disorders may experience impairments in daily 
life, such as restrictions in physical activity, travelling and school 
participation.5‐7 Concerns exist about the long‐term impact of the 
disease and its treatment on adaptation and functioning in adult life. 
Most studies focus on physical complications (eg, prevention of joint 
damage and inhibitor development),8,9 but important measures of 
successful treatment in childhood should also include the level of 
achieved independency, and professional and social participation in 
adulthood.10‐12 Finding an education or job that fits with some of 
the physical restrictions that YA with CCD encounter is important to 
strengthen work‐related psychosocial skills.13‐15
In two previous studies among the same patients as in the present 
study, we have found that, despite growing up in the current era and 
in a resource rich country with adequate treatment available, young 
adults (YA) with CCD in the Netherlands still experience obstacles and 
issues in daily life with regard to their treatment and condition.5,6 For 
example, lower health‐related quality of life (HRQOL), lower self‐es‐
teem and a lower rate of paid jobs were found in YA men with CCD 
compared to healthy peers,6 which has also been found in the US.16,17 
Research conducted in 2001 in the Netherlands also demonstrated 
that adult men with severe haemophilia participated less in full‐time 
work compared with the general population,18 a finding which is com‐
mon in chronically ill populations.19,20 Unemployment among patients 
with CCD is an issue of concern from a societal perspective.
Impairment in professional functioning among people with 
chronic illness often seems to be related to pain, fatigue and physical 
limitations.21 However, a considerable discrepancy between the level 
of functioning experienced by patients and the underlying pathology 
of the disease is often found. In patients with the same severity of 
disease, physical, mental and social problems experienced can vary 
from patient to patient and has therefore led to hypotheses about 
the contribution of psychosocial factors to health outcomes.19,22 So 
far, literature on the role of psychosocial factors in relation to pro‐
fessional functioning in patients, and especially young adults, with 
CCD is scarce.19,23 One study has shown that feelings about social 
stigma can hinder patients with CCD in finding employment.14 Other 
literature has shown that many haemophilia patients select their job 
or training taking into account their limitations related to haemo‐
philia (eg, jobs with not too much physical activity or without a risk 
of trauma) and that some patients believe that they have lost a job in 
the past because of their haemophilia.24,25
Suboptimal HRQOL and low employment rates found in a pre‐
vious study6 have led us to conceive the current study, in which we 
aim to gain more in‐depth insight into professional functioning (paid 
employment, impairment in working) of YA with CCD and to assess 
whether sociodemographics, disease characteristics, functional dis‐
abilities, physical HRQOL and illness cognitions are associated with 
professional functioning.
2  | MATERIAL AND METHODS
2.1 | Participants
Young adult men and women aged 18‐30 years with haemophilia 
A/B, VWD type 2 or 3 or other congenital coagulation disorders 
were eligible for participation if they were able to complete Dutch 
online questionnaires. Patients under treatment in one of the 
three participating haemophilia treatment centres (HTC's) in the 
Netherlands (Amsterdam UMC, Erasmus University Medical Center 
Rotterdam and Leiden University Medical Center) or YA who are a 
member of the Dutch Hemophilia Patient Society Young Adult com‐
mittee (DHPSYA) were included (Table 1).
2.2 | Procedure
Invitational letters, including login codes for online questionnaires, 
were sent out between May and October 2015 to the eligible pa‐
tients of the HTC's and to members of the DHPSYA after approval by 
the Medical Ethics Committees of the Amsterdam UMC, and Leiden 
University Medical Center. To recruit additional respondents, the 
DHPSYA posted an online call for participation on their website and 
Facebook page. Informed consent was obtained from all participants 
prior to completing questionnaires.
2.3 | Measures
2.3.1 | Sociodemographic and disease 
characteristics
Sociodemographic information of the participants was collected 
with questions from the Course of Life Questionnaire (CoLQ),26 
regarding age, gender, country of birth, education and marital sta‐
tus. Education was divided into three categories according to the 
classification of Statistics Netherlands (www.cbs.nl); low (primary 
education, lower vocational education, lower and middle general 
secondary education), middle (middle vocational education, higher 
secondary education, pre university education) and high (higher 
vocational education, university). Additionally, respondents were 
asked medical questions regarding the type of disease, severity 
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(severe haemophilia: <1% clotting factor VIII or IX present in blood; 
non‐severe haemophilia: 1%‐40% clotting factor VIII or IX), treat‐
ment and number of bleeds that occurred over the past 6 months.
2.3.2 | Professional functioning: Work 
Productivity and Activity Impairment questionnaire 
(WPAI)
The Work Productivity and Activity Impairment (WPAI) question‐
naire is a validated self‐report questionnaire that assesses the 
impact of disease on work and other daily activities.27 For the pre‐
sent study about professional functioning, the Dutch WPAI items 
about work were used: paid employment (yes/no), if yes: average 
working hours per week; number of missed hours at work the last 
7 days due to the disease; degree of disease influence on work pro‐
ductivity the last 7 days (0‐10, where 0 indicates no influence and 
10 indicates that the disease completely prevented to do the job). 
Three outcomes are derived from the WPAI work‐related items 
as follows: (a) Absenteeism (% worktime missed: missed hours at 
work in the last 7 days due to the disease divided by the average 
TA B L E  1   Characteristics of young adults with coagulation disorders (CCD) by gender
Men with CCD Women with CCD
N M (SD) N M (SD)
Sociodemographic characteristics
Age 77 24.14 (3.53) 17 24.59 (3.79)
N % N %
Country of birth (Netherlands) 68 88.3 16 94.1
Educationa 
High 19 24.7 7 41.2
Middle 43 55.8 6 35.3
Low 15 19.5 4 23.5
Marital status (married/living together) 21 27.3 6 35.3
CCD characteristics
Type of coagulation disorder
Haemophilia A 55 71.4 1 5.9
Haemophilia B 14 18.2 0 0.0
Von Willebrand type 2/3 5 7.8 10 58.8
Other congenital coagulation disorder 2 2.6 6 35.3
Type of treatment coagulation disorder
Prophylaxis 37 48.1 1 5.9
On demand ‐ in case of bleed 40 51.9 16 94.1
Severity of haemophilia
Non‐severe (>1%) 35 50.7 1 5.9
Severe (<1%) 34 49.3 0 0.0
Median 
(range)
Median  
(range)
Number of bleeds past 6 mo requiring treatment 1.00 (0‐20) 0.00 (0‐20)
Functional disabilities (HAL scores)b,c  N M (SD)
Upper extremity activities 69 92.82 (18.56)
Basic lower extremity activities 69 86.43 (22.87)
Complex lower extremity activities 69 85.51 (21.86)
Sum score 48 90.99 (20.75)
M, mean; SD, standard deviation; HAL, Haemophilia Activities List, scoring 0‐100 with higher scores representing better functioning.
ahigh = higher vocational education, university; middle = middle vocational education, higher secondary education, pre university education; low = pri‐
mary education, lower vocational education, lower and middle general secondary education 
bOnly assessed in men with haemophilia. 
c21 respondents had a missing value “not applicable” on one or more items. 
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working hours per week multiplied by 100); (b) Presenteeism [% 
impairment while working due to the disease, that is, the de‐
gree (0‐10) the disease influenced work productivity divided by 
10 and multiplied by 100]; (c) Overall work impairment, which is 
a combination of absenteeism and presenteeism: absenteeism + 
([100‐absenteeism] × presenteeism).
For all three outcomes, a higher percentage indicates more work 
impairment. For use in the present analyses, the three outcomes 
were dichotomized into whether or not (0% vs >0%) Absenteeism, 
Presenteeism or Overall work impairment was present. For 
Presenteeism and Overall work impairment, there were no scores 
between 0% and 10%, so for the concerning dichotomous variables, 
we used “<10% vs ≥10%”.
2.3.3 | Haemophilia Activities List (HAL)
The Haemophilia Activities List (HAL) was used in YA men with 
haemophilia only (N = 69), to assess self‐perceived limitations 
in activities (functional disabilities).28 The HAL is a disease‐spe‐
cific questionnaire with 42 items in seven domains of disabilities, 
which are based on the International Classification of Functioning, 
Disability and Health (ICF)29: lying down/sitting/kneeling/stand‐
ing (8 items), functions of the legs (9 items), functions of the 
arms (4 items), use of transportation (3 items), self‐care (5 items), 
household tasks (6 items), leisure activities, and sports and other 
activities (7 items). Answers are given on a six‐point Likert scale, 
ranging from “impossible” (1), “always problems with” (2) to “never 
problems with” (6). The items in the domains of transportation, 
household tasks and leisure activities have the additional answer 
option “not applicable”. Consequently, these scores were recorded 
as missing value. Three component scores “upper extremity activi‐
ties” (range 9‐54), “basic lower extremity activities” (range 6‐36) 
and “complex lower extremity activities” (range 9‐54) are calcu‐
lated, as well as a sum score of all items (range 42‐252). Answers 
are rescaled and normalized to a 0‐100 scale, with higher scores 
representing better functional status. The validity and reliabil‐
ity of the HAL are good in adult patients with haemophilia.28,30 
Cronbach's alpha in the present study ranged from 0.93 (function 
of arms) to 0.98 (self‐care) for the domain scores and from 0.95 
(complex lower extremity activities) to 0.99 (sum score) for the 
component scores.
2.3.4 | Pediatric Quality of Life Inventory (PedsQL 
4.0) generic core scales young adult version
The physical health scale (8 items) of the Dutch version of the 
Pediatric Quality of Life Inventory generic core scales young adult 
version (PedsQL_YA; 18‐30 years) was used.31,32 The PedsQL_YA is 
a generic HRQOL instrument and consists of 23 items in total. Each 
item states a problem, for example, “it is hard for me to run”. On a 
5‐point Likert scale, ranging from “never” (0) to “almost always” (4), 
the patient indicates whether he/she had problems with that item. 
Each answer is reversed scored and rescaled to a 0‐100 scale so that 
higher scores indicate better reported physical functioning. The va‐
lidity and reliability of the PedsQL_YA scales are good.32 Cronbach's 
alpha of the physical health scale in our sample was 0.86.
2.3.5 | Illness Cognitions Questionnaire (ICQ)
To assess illness cognitions, the Dutch Illness Cognition Questionnaire 
(ICQ) was used. The ICQ is developed for adults which measures illness 
beliefs across various chronic conditions.33 It contains 18 items in three 
scales, related to cognitive ways patients ascribe meaning to chronic 
illness: helplessness (6 items), acceptance (6 items) and perceived dis‐
ease benefits (6 items). Answers are given on a four‐point Likert scale 
ranging from “not at all” (1) to “completely” (4). Scale scores are calcu‐
lated by summing up the item scores. Higher scores indicate stronger 
presence of the illness cognition. The validity and reliability of the ICQ 
scales are good .33,34 Cronbach's alpha in the present study ranged 
from 0.79 (acceptation) to 0.86 (helplessness and disease benefits).
2.4 | Data analysis
Descriptive analyses were performed to characterize the YA with 
CCD and to gain insight in their professional functioning.
Next, logistic regression analyses were performed to identify po‐
tential determinants of professional functioning (WPAI outcomes: 
paid employment status, Presenteeism and Overall work impairment): 
sociodemographics and disease characteristics (see Table 1), func‐
tional disabilities, physical HRQOL and illness cognitions. Due to low 
variance, Absenteeism (see Table 2) could not be used as an outcome 
in the logistic regression analyses. Logistic regression analyses were 
performed for all CCD and separately for men with haemophilia.
Because of the large number of variables in relation to the sam‐
ple size, preselection was necessary. Sociodemographic (country of 
birth, education and marital status) and disease characteristics (type 
of coagulation disorder, type of treatment, severity of haemophilia 
and number of bleeds), physical HRQOL (PedsQL_YA), illness cogni‐
tions (helplessness, acceptance, disease benefits; ICQ) and, in hae‐
mophilia only, functional disabilities (HAL component scores: upper 
extremity activities, basic lower extremity activities, complex lower 
extremities and sum score) were included in the logistic regression 
TA B L E  2   Professional functioning of young adults with 
coagulation disorders (CCD) by gender
Men with CCD
Women with 
CCD
N % N %
Paid employment (yes) 58 75.3 12 70.6
Absenteeism: >0% working 
hours missed due to CCD
3 5.2 0 0.0
Presenteeism: ≥10% impairment 
while working due to CCD
14 24.1 2 16.7
Overall work impairment: ≥10% 
due to CCD
14 24.1 2 16.7
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models if significantly (P < 0.05) associated with the WPAI outcomes 
in univariate analyses (according to Pearson correlation or χ2 tests). 
All logistic regression analyses were controlled for age. Gender was 
not included in the models because it was strongly associated with 
characteristics of the disease. The results of the logistic regression 
analyses are expressed as Odds Ratios (OR) with 95% confidence in‐
tervals (CI).
3  | RESULTS
3.1 | Characteristics of YA with CCD
In total, 94 YA completed the online questionnaires (52% overall re‐
sponse rate): 34 YA (46% response rate) from the Amsterdam UMC, 
37 YA (46% response rate) from the Erasmus University Medical 
Center Rotterdam, 10 YA (33% response rate) from the Leiden 
University Medical Center and 10 YA from the DHPSYA (83% re‐
sponse rate). An online call yielded another 3 YA. The mean age of 
the 77 men (81.9%) was 24.1 years (SD 3.5) and of the 17 women 
(18.1%) 24.6 years (SD 3.8). Table 1 presents the sociodemographic 
and disease characteristics of the study population and functional 
disabilities (HAL) of the subgroup of YA men with haemophilia.
3.2 | Professional functioning
Table 2 presents professional functioning according to the WPAI 
outcomes per gender. Out of 94 participating YA, 70 (74.5%) YA 
were paid employed. These 70 YA worked on average 29.8 (SD 14.0) 
hours per week. In the age group 18‐25 years, 64% of YA were paid 
employed, while in the age group 26‐30 years, 92% were paid em‐
ployed. Absenteeism of 3%‐25% of their average working hours was 
present in 4.3% (N = 3) of the YA with paid employment. Of the 70 
YA with paid employment, 22.9% (N = 16) were ≥10% impaired while 
working due to CCD (Presenteeism), and 22.9% (N = 16) had ≥10% 
Overall work impairment due to CCD.
3.3 | Determinants of professional functioning
3.3.1 | Total cohort of YA with CCD
Older YA with CCD were more likely to have paid employment (OR 
1.30 95% CI 1.1‐1.5; data not shown). The results of the other lo‐
gistic regression analyses are shown in Table 3. Presenteeism and 
Overall impairment due to CCD while working was not associated 
with sociodemographic and disease characteristics, physical HRQOL 
and illness cognitions.
3.3.2 | YA men with haemophilia
In the group of YA men with haemophilia, older patients (OR 1.21 
95% CI 1.1‐1.4) and patients with non‐severe haemophilia (OR 7.82 
95% CI 2.8‐21.8; data not shown) were more likely to have paid em‐
ployment. The results of the other logistic regression analyses are 
shown in Table 4. None of the variables included in the logistic re‐
gression models were significantly associated with Presenteeism or 
Overall impairment due to CCD while working were not associated 
with sociodemographic and disease characteristics, functional dis‐
abilities, physical HRQOL and illness cognitions.
4  | DISCUSSION AND CONCLUSION
This study examined professional functioning in young adult (YA) 
patients with congenital coagulation disorders (CCD). The results 
showed that three‐quarters of YA with CCD were paid employed for 
on average 30 hours per week, which does not seem bad taking into 
account that the YA who were student cannot be expected to work 
full time (36‐40 hours per week). Non‐severe type of haemophilia 
was associated with a greater likelihood of being paid employed and 
the older the YA the more likely that the YA was paid employed. 
In the age group 26‐30 years, when most YA have completed their 
education, paid employment was 92%. Of those with a paid job, one‐
quarter reported work impairment of ≥10%. Among those with a 
paid job, no sociodemographic, disease or other variables (functional 
disabilities, physical HRQOL and illness cognitions) were found to be 
associated with work impairment.
Compared to adults with other chronic illnesses, YA with CCD 
seemed to have adjusted well to a job once they have found one. 
In our sample, rates of missed working time and rates of work im‐
pairment were low in comparison to WPAI outcomes in adults with 
other chronic illnesses.35,36 However, this comparison is hampered 
by the fact that our sample consisted of YA who have grown up with 
a congenital disease while the other studies concerned patients who 
became ill in adulthood. As a result, the latter patients may not have 
been able to take their current illness into account when choosing 
their career. Another explanation for the favourable outcomes could 
be that YA with worse employment outcomes did not participate in 
our study. Nevertheless, the low absenteeism we found in the YA 
with CCD indicates that patients with CCD in the Netherlands have 
TA B L E  3   Logistic regression model of work impairment (WPAI 
outcomes) for young adults with CCD (N = 70)
Impairment while 
working due to CCD 
≥10%
Overall work impair‐
ment due to CCD  
≥10%
Odds Ratio 
(CI 95%) P‐value
Odds Ratio 
(CI 95%) P‐value
Bleeds (≥1 
past 6 mo)
1.76 
(0.34‐9.01)
0.50 1.76 
(0.34‐9.01)
0.50
Physical 
HRQOL
0.94 
(0.89‐1.01)
0.07 0.94 
(0.89‐1.01)
0.07
Helplessness 1.37 
(0.92‐2.03)
0.12 1.37 
(0.92‐2.03)
0.12
Acceptation 0.91 
(0.68‐1.22)
0.54 0.91 
(0.68‐1.22)
0.54
HRQOL, health‐related quality of life, as measured with PedsQL_YA.
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adjusted well to their chronic disease status and are able to find a job 
that fits with their impairments. This could be due to the fact that 
half of the sample consisted of YA with non‐severe CCD and that 
the patients with severe CCD used prophylaxis, which is common in 
the Netherlands. Prophylaxis limits joint damage which in turn could 
help prevent work disabilities. The fact that older patients did not 
score worse on the Haemophilia Activity List than younger patients 
(data not shown) is in line with this explanation because without 
prophylaxis, older YA with CCD would be more likely to suffer from 
joint damage than younger YA with CCD. That the patients are doing 
well, is probably also a spinoff of the enormous improvement in the 
care for haemophilia patients in the Netherlands in the last two de‐
cades. Treatment and care are concentrated in a small number of 
Haemophilia treatment centres, where multidisciplinary teams in‐
cluding social workers and/or paediatric psychologists are aware of 
psychosocial problems.
However, the percentage of YA with CCD that reported work im‐
pairment due to their disease (22.3% and 32.9%) is not negligible. In 
daily practice, it is important to monitor whether the requirements 
of the job match the possibilities of the YA with CCD not only when 
YA are in search of a job but also once they have found a job. It is 
recommended to screen whether YA need additional support in find‐
ing or doing their job by asking them to complete Patient‐Reported 
Outcomes Measures (PROMs) before an outpatient visit, for exam‐
ple by using the KLIK portal.37 Healthcare providers could refer the 
YA's to social workers or a job agency specialized in helping adoles‐
cents and young adults with chronic illness. Such an agency is “Emma 
at Work”, a job mediation agency for adolescents with a somatic dis‐
ease.38 Founded by the Emma Children‘s Hospital Amsterdam UMC, 
it is now also located in other hospitals in the Netherlands and is 
open for all young people with a chronic condition. Moreover, it is 
important that employers are encouraged to adjust the workload 
and tasks to fit the abilities of patients, especially for those on pro‐
phylactic treatment.5,16,17
Previous studies among patients with haemophilia showed that 
physical limitations and pain did interfere with daily activity and 
work39,40 and that professional functioning was associated with pain, 
fatigue and other physical limitations,16,17,23 findings which we could 
not confirm in our study. Unfortunately, we did not assess pain and 
fatigue in our study, which would be interesting to include in the 
future, since it is known that pain is also negatively associated with 
physical and mental HRQOL.39 Apart from age and severity of the 
CCD, we found no associations between professional functioning and 
sociodemographics (eg, educational level and marital status), disease 
characteristics (eg, number of bleeds and type of treatment), func‐
tional disabilities, physical HRQOL and illness cognitions. We do not 
have information on the type of work that YA perform, which would 
have been interesting to relate to the degree of work impairment 
experienced.
This study has a few limitations to take into account. First, 
though the response rates of the patients from the HTC's and 
the DHPSYA were satisfactory, we do not know whether the re‐
sults are representative for YA with coagulation disorders in the 
Netherlands since sociodemographic and medical information of 
many non‐respondents was unknown. Second, we were not able 
to compare the WPAI outcome “paid employment” to a healthy 
norm group because this information was not available. However, 
from a previous study among the same patients as in the present 
study,6 it has already been known that the rate of paid employ‐
ment was significantly lower in men with CCD than in male peers 
from the general population. Third, although the sample size was 
reasonably large, the power to detect determinants of the profes‐
sional outcomes was still limited.
In conclusion, three‐quarters of YA with CCD in the Netherlands 
were successful in finding paid employment. Though absenteeism 
was low among the YA with paid employment, employed YA with 
CCD need attention as more than one quarter of them experienced 
impairment in professional functioning.
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